
RXRX vs COAG
$RXRX vs $COAG head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RXRX vs COAG: the quick read
- ·RXRX is the larger company by market cap ($2.05B vs $1.92B).
- ·RXRX has been more active on our scanner (215 vs 58 alerts in 30 days).
- ·COAG has the smaller float (40.6M vs 536.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·They trade in different worlds by share price: RXRX is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·RXRX draws far more of our scanner's attention, 215 unusual-volume alerts in 30 days against 58, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 7% of each other on market cap, which makes the rest of this table the interesting part.
- ·COAG is the one in play today, trading about 12x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RXRX and COAG on TheDesperateTrader.
- Is RXRX or COAG the better stock?
- "Better" depends on your goal, and these two are not alike. RXRX is the larger company by market cap ($2.05B vs $1.92B). RXRX has been more active on our scanner (215 vs 58 alerts in 30 days). COAG has the smaller float (40.6M vs 536.3M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RXRX and COAG?
- The differences that matter: they are not in the same business - RXRX is biological products, (no diagnostic substances) and COAG is biological products, (no diagnostic substances); they are similar in size ($2.05B vs $1.92B); they trade at very different share prices ($3.80 vs $41.19); RXRX sits at 23% of its 52-week range against 56% for COAG; our scanner flagged RXRX 215 times in the last 30 days against 58 for COAG. Everything above is measured from the latest completed session and SEC filings.
- Which of RXRX and COAG is more active right now?
- Right now RXRX is at about 2.8x its normal volume and COAG is at about 11.9x, so COAG is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RXRX or COAG? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RXRX and COAG comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.